Posts

Showing posts with the label Pharmaceutical raw materials

Challenges for Pakistan Pharma Industry in 2023 – Part 2 – Asrar Qureshi’s Blog Post #772

Image
Challenges for Pakistan Pharma Industry in 2023 – Part 2 – Asrar Qureshi’s Blog Post #772 Dear Colleagues!  This is Asrar Qureshi’s Blog Post #772 for Pharma Veterans. Pharma Veterans welcome sharing of knowledge and wisdom by Veterans for the benefit of Community at large. Pharma Veterans Blog is published by Asrar Qureshi on  WordPress, the top blog site. Please email to asrar@asrarqureshi.com for publishing your contributions here. Photo Credit: Anna Tarazevich Photo Credit: Edward Jenner Photo Credit: Karolina Grabowska Cost of Quality Control – Quality control of APIs is more stringent and rightly so. Several steps are needed at various stages of production to remove chemicals used in processing, which are many and must be removed completely, or kept in a narrow, acceptable range. The CoA – Certificate of Analysis must mention the detail of such residual materials. The finished goods manufacturers rely on the CoA of API manufacturer; even otherwise, they do not have the ...

Pakistan Pharma Industry SWOT – Part 3 – Asrar Qureshi’s Blog Post #594

Image
Pakistan Pharma Industry SWOT - Part 3 - Asrar Qureshi's Blog Post #594 Dear Colleagues!  This is Asrar Qureshi’s Blog Post #594 for Pharma Veterans. Pharma Veterans welcome sharing of knowledge and wisdom by Veterans for the benefit of Community at large. Pharma Veterans Blog is published by Asrar Qureshi on WordPress, the top blog site. Please email to asrar@asrarqureshi.com for publishing your contributions here. Opening Note February 2022 shall mark my completing 47 years of working in Pharma Industry. Allah be praised. I am still working. The first half of my working career was spent in Multinational companies, and the latter half in the Local Pharma, making me well-versed with both innovators and generics markets. I also had the opportunity to work in business as well as operations.  My journey of near half century is also the journey of Pharma Industry in Pakistan. Great changes have occurred in this time and a lot could be written about it. In my blogs, which were star...

Pakistan Pharma Industry SWOT – Part 2 – Asrar Qureshi’s Blog Post #593

Image
Pakistan Pharma Industry SWOT – Part 2 – Asrar Qureshi’s Blog Post #593 Dear Colleagues!  This is Asrar Qureshi’s Blog Post #593 for Pharma Veterans. Pharma Veterans welcome sharing of knowledge and wisdom by Veterans for the benefit of Community at large. Pharma Veterans Blog is published by Asrar Qureshi on WordPress, the top blog site. Please email to asrar@asrarqureshi.com for publishing your contributions here. Opening Note February 2022 shall mark my completing 47 years of working in Pharma Industry. Allah be praised. I am still working. The first half of my working career was spent in Multinational companies, and the latter half in the Local Pharma, making me well-versed with both innovators and generics markets. I also had the opportunity to work in business as well as operations.  My journey of near half century is also the journey of Pharma Industry in Pakistan. Great changes have occurred in this time and a lot could be written about it. In my blogs, which were star...

GST Levy on Pharmaceuticals – Pharma Veterans’ Blog Post #583 by Asrar Qureshi

Image
GST Levy on Pharmaceuticals – Pharma Veterans’ Blog Post #583 by Asrar Qureshi Dear Colleagues!  This is Pharma Veterans’ Blog Post #583. Pharma Veterans welcome sharing of knowledge and wisdom by Veterans for the benefit of Community at large. Pharma Veterans Blog is published by Asrar Qureshi on WordPress, the top blog site. Please email to asrar@asrarqureshi.com for publishing your contributions here. News reports say that the government has finalized the mini-budget to raise about 360 billion rupees by levying 17% General Sales Tax – GST on 140 items or so. The items include milk, cereals, bakery items, meat, chicken, gold, bicycles, cars including electric cars, mobile phones, phone calls, pharmaceutical raw materials and so on.  It is yet a draft which will have to be approved by the parliament so that it could be implemented. Considering that most members of our parliament either do not understand such technical matters (the rest understand too well and try to manipulat...